‘Half’ the current chemo could prevent testicular cancer returning
Testicular cancer is the most common cancer affecting young men, with many patients being diagnosed in their twenties or thirties.
Read More
Tag: chemo
US priority review for Keytruda/chemo combo in first-line squamous NSCLC
US regulators have assigned a priority review to MSD’s application to market the immunotherapy Keytruda in combination with chemotherapy as a first-line treatment for squamous non-small cell lung cancer (NSCLC).
Read More
- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
- Sobi to acquire Arthrosi Therapeutics, strengthening gout treatment pipeline
- Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
- Title21 Health Solutions joins the Blood and Cells Advocacy Roster
- NADMED launches $30,000 metabolomics research award
